Huixiong Xu
Overview
Explore the profile of Huixiong Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guan X, Shen Y, Zhao C, Li X, Li X, Lu D, et al.
Adv Healthc Mater
. 2025 Mar;
:e2500176.
PMID: 40079115
The abnormal tumor mechanical microenvironment due to specific cancer-associated fibroblasts (CAFs) subset and low tumor immunogenicity caused by inefficient conversion of active chemotherapeutic agents are two key obstacles that impede...
2.
Zhan R, Fang Y, Lou C, Chen N, Mo X, Jiao B, et al.
Adv Sci (Weinh)
. 2025 Mar;
:e2414397.
PMID: 40047133
Postoperative cognitive dysfunction (POCD) frequently occurs after surgery, resulting in extended hospitalizations, higher healthcare expenses, and potential long-term cognitive impairment. Despite its significant impact, effective preventive and therapeutic strategies for...
3.
Fan Y, Chen K, Zhao Q, Yin H, Zhu Y, Xu H
Clin Hemorheol Microcirc
. 2025 Feb;
:13860291241304057.
PMID: 39973438
Objective: To evaluate the diagnostic performance of novel tissue attenuation imaging (TAI) and tissue scatter distribution imaging (TSI) tools in detecting and grading hepatic steatosis using controlled attenuation parameter (CAP)...
4.
Qian X, Yi W, Yan W, Cai Y, Hu S, Yan D, et al.
Adv Mater
. 2025 Feb;
:e2413289.
PMID: 39955715
Ultrasound therapy has turned up as a noninvasive multifunctional tool for cancer immunotherapy. However, the insufficient co-stimulating molecules and loss of peptide-major histocompatibility complex I (MHC-I) expression on tumor cells...
5.
Li S, Yu J, Shen Y, Xiong B, Zhao D, Xu W, et al.
Nat Commun
. 2025 Feb;
16(1):1499.
PMID: 39929846
Obesity, a surging global health challenge, necessitates effective, accessible and innovative therapeutic models. Here we develop a spatiotemporally controllable microneedle (MN) drug delivery platform for sono-gene therapy to fight obesity....
6.
Dong B, He R, Ju S, Chen Y, Grgurevic I, Ma J, et al.
Clin Mol Hepatol
. 2025 Feb;
PMID: 39905838
Background/aims: A large percentage of patients undergoing esophagogastroduodenoscopy (EGD) screening do not have esophageal varices (EV) or have only small EV. We evaluated a large, international, multicenter cohort to develop...
7.
Yang Y, Gong Y, Shen W, Fan Y, Yin H, Wang W, et al.
Abdom Radiol (NY)
. 2025 Jan;
PMID: 39794534
Objectives: The objective of this study was to evaluate the role of Liver Stiffness Measurement (LSM) and serum transaminase levels for predicting early allograft failure (EAF) after liver transplantation (LT)....
8.
Yu J, Li S, Xiong B, Shen Y, Guan X, Zhu Y, et al.
Adv Mater
. 2024 Dec;
37(4):e2412429.
PMID: 39641224
Inflammatory bowel disease presents significant treatment challenges owing to its complex pathology. Although probiotics have shown promise as a therapeutic option, their effectiveness is often limited by low concentrations at...
9.
Wang P, Xia H, Liu L, Wang X, Yan L, Kong Z, et al.
Ultrasound Q
. 2024 Nov;
40(4).
PMID: 39590515
This study aimed to assess the effectiveness of intelligence-based computer-aided diagnosis (CAD) software in ultrasound (US) and its potential to improve the diagnostic performance of less experienced radiologists, as well...
10.
Guan X, Han H, Xu H
Ultrasonography
. 2024 Nov;
44(1):5-18.
PMID: 39557016
Lower-extremity vascular disease has a high morbidity rate and often leads to disability and death in its advanced stages. Although angiography-guided endovascular intervention is the primary treatment for peripheral vascular...